Last Round
Grant
Dec 5, 2024
Total Funding Raised
$30,000
Company Overview
B3 Therapeutics operates in Healthcare & Life Sciences and is based in New Haven, Connecticut. Its latest recorded funding round was a Grant round in December 2024.
B3 Therapeutics is a biotechnology company developing a novel approach to treat brain tumors using sustained-release, nanoparticle-encapsulated drugs delivered directly into the central nervous system.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
B3 Therapeutics Comparables
Compare B3 Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Nanocarry Therapeutics | 81% | |
| B³ Pharma | 81% | |
| Gate2Brain | 77% |
For institutional investors. Book with your work email.
B3 Therapeutics Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
B3 Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Blavatnik Fund for Innovation at Yale | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 5, 2024
$30K grant from Blavatnik Fund for Innovation at Yale.
For institutional investors. Book with your work email.
B3 Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about B3 Therapeutics's valuation, stock price, and market status.
Is B3 Therapeutics a public or private company?
B3 Therapeutics is a private company.
What is the current stock price of B3 Therapeutics?
B3 Therapeutics is a private company, so its shares have no public market price. Caplight tracks B3 Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is B3 Therapeutics worth (valuation)?
Valuation information for B3 Therapeutics is not publicly available.
Can I buy B3 Therapeutics stock?
B3 Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was B3 Therapeutics's last funding round?
B3 Therapeutics's most recent funding round was Grant on December 5, 2024.
Who are the main investors in B3 Therapeutics?
Key investors in B3 Therapeutics include Blavatnik Fund for Innovation at Yale.
Will B3 Therapeutics IPO soon?
No public IPO plans have been announced for B3 Therapeutics.
How can I track B3 Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in B3 Therapeutics's shares on secondary markets.